Procter & Gamble Health Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 29, 2025
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Procter & Gamble Health Limited held its 58th Annual General Meeting on August 29, 2025 via video conferencing, chaired by Mr. S Madhavan. Shareholders approved the audited financial statements for the transition period (9 months from July 2024 to March 31, 2025) following the company's change in financial year from July-June to April-March. Key resolutions included confirmation of interim dividend and declaration of final dividend for FY ending March 2025, re-appointment of Ms. Seema Sambasivan as Non-Executive Director (retiring by rotation), appointment of M/s Dholakia & Associates as Secretarial Auditors for five years, and ratification of Cost Auditor remuneration for FY 2025-26. The Auditors' Report contained no qualifications. Business highlights shared at the meeting showed 8% sales growth and 27% profit after tax growth over the comparable 9-month period, with INR 40 crore in productivity savings. The company also reported 7% sales CAGR and 9% PAT CAGR over the past 5 years, alongside 34% ROE increase.
Routine AGM proceedings with all standard resolutions put to vote; the confirmed final dividend is a positive for shareholders. Strong double-digit profit growth of 27% (on a comparable basis) signals healthy operational momentum, though the 9-month transition year makes year-on-year comparisons limited until FY26.